Table 2.

Characteristics of the ESBLE^a

Species and ESBL type	Additionnal β lactamase			Acquired co-resistanceb
	non ESBL SHV	TEM1-like	OXA-1 like	SXT	GM	CIP	TE
K. pneumoniae (24)
CTX M-15 (21)	16	11	11	14	11	21	11
CTX M-1 (2)	1	1	1	1	2	2	2
SHV-12 (1)	-	-	-	1	-	2	-
E. coli (11)
CTX M-15 (5)	-	2	-	3	2	3	3
CTX M-1 (4)	-	3	-	4	2	1	3
CTX M-14 (1)	-	1	-	-	1	1	1
CTX M-27 (1)	-	1	1	1	-	1	1
E. cloacae (2)
CTX M-15 (2)	-	2	2	2	1	2	1
E. aerogenes
CTX M-1	-	-	-	-	-	-	-
M. morganii
CTX M-15	-	-	-	1	1	1	1

^aNumber of strains is indicated in parentheses when >1

^b SXT cotrimoxazole, GM gentamicin, CIP ciprofloxacin, TE tetracyclin